Let’s start up with the current stock price of Altimmune Inc. (ALT), which is $9.31 to be very precise. The Stock rose vividly during the last session to $9.33 after opening rate of $8.74 while the lowest price it went was recorded $8.29 before closing at $8.74.Recently in News on November 22, 2022, Altimmune to Participate at Two Upcoming Investor Conferences. Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that members of the Company’s management team will participate at the following investor conferences:. You can read further details here
Altimmune Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $23.49 on 09/02/22, with the lowest value was $3.83 for the same time period, recorded on 05/12/22.
Altimmune Inc. (ALT) full year performance was -8.73%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Altimmune Inc. shares are logging -60.37% during the 52-week period from high price, and 143.08% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $3.83 and $23.49.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 801386 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Altimmune Inc. (ALT) recorded performance in the market was 1.64%, having the revenues showcasing -51.74% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 455.07M, as it employees total of 47 workers.
Market experts do have their say about Altimmune Inc. (ALT)
During the last month, 0 analysts gave the Altimmune Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 13.36, with a change in the price was noted -1.95. In a similar fashion, Altimmune Inc. posted a movement of -17.32% for the period of last 100 days, recording 2,026,657 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ALT is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Technical breakdown of Altimmune Inc. (ALT)
Raw Stochastic average of Altimmune Inc. in the period of last 50 days is set at 12.27%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 20.40%. In the last 20 days, the company’s Stochastic %K was 10.53% and its Stochastic %D was recorded 5.91%.
Bearing in mind the latest performance of Altimmune Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 1.64%. Additionally, trading for the stock in the period of the last six months notably improved by 97.25%, alongside a downfall of -8.73% for the period of the last 12 months. The shares increased approximately by -14.74% in the 7-day charts and went down by -14.04% in the period of the last 30 days. Common stock shares were lifted by -51.74% during last recorded quarter.